The effect of vitamin C on nitroglycerin‐mediated vasodilation in individuals with and without the aldehyde dehydrogenase 2 polymorphism

Aims To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH‐2) has been proposed as the primary enzyme...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of clinical pharmacology Vol. 89; no. 9; pp. 2767 - 2774
Main Authors He, Jerry D., Parker, John D.
Format Journal Article
LanguageEnglish
Published England 01.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aims To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH‐2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH‐2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH‐2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH‐2 polymorphism participated. Methods Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30‐min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN. Results Compared to subjects with functional ALDH‐2, the variant group exhibited blunted hemodynamic responses to intra‐arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups. Conclusion We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH‐2 polymorphism.
AbstractList To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH-2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH-2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH-2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH-2 polymorphism participated.AIMSTo mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH-2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH-2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH-2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH-2 polymorphism participated.Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30-min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN.METHODSSubjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30-min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN.Compared to subjects with functional ALDH-2, the variant group exhibited blunted hemodynamic responses to intra-arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups.RESULTSCompared to subjects with functional ALDH-2, the variant group exhibited blunted hemodynamic responses to intra-arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups.We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH-2 polymorphism.CONCLUSIONWe conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH-2 polymorphism.
Aims To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH‐2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH‐2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH‐2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH‐2 polymorphism participated. Methods Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30‐min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN. Results Compared to subjects with functional ALDH‐2, the variant group exhibited blunted hemodynamic responses to intra‐arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups. Conclusion We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH‐2 polymorphism.
To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH-2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH-2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH-2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH-2 polymorphism participated. Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30-min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN. Compared to subjects with functional ALDH-2, the variant group exhibited blunted hemodynamic responses to intra-arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups. We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH-2 polymorphism.
Author He, Jerry D.
Parker, John D.
Author_xml – sequence: 1
  givenname: Jerry D.
  surname: He
  fullname: He, Jerry D.
  organization: University of Toronto
– sequence: 2
  givenname: John D.
  orcidid: 0000-0003-1949-2669
  surname: Parker
  fullname: Parker, John D.
  email: john.parker@uhn.ca
  organization: The Lunenfeld‐Tanenbaum Research Institute, Sinai Health System
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37101414$$D View this record in MEDLINE/PubMed
BookMark eNp1kb1uFDEUhS0URDaBghdALkkxiX_GM7slrAggRSJFUlse-w5r5LEH27PRdNSp8ow8Cd6fNAgsS9fFd451zzlDJz54QOgtJZe0nKtOj5dUtEK8QAvKG1ExysQJWhBOmkowQU_RWUo_CKGcNuIVOuUtJbSm9QI93m0AQ9-Dzjj0eGuzGqzHaxw89jbH8N3NGqL1v389DWCsymDwVqVgrFPZFsrurrFbayblEn6weYOVN_tHmDLO5QPlDGxmA3g_iil4lQAzPAY3DyGOG5uG1-hlXxzgzXGeo_vrT3frL9XNt89f1x9uKs2ZEJURplGCMdFS3XFBdEtALVVd9mddLRQlumt0o0jPNKOrZc04b7slGN2B6Wrg5-j9wXeM4ecEKcvBJg3OKQ9hSpItSbNatQ2rC_ruiE5d2V6O0Q4qzvI5vwJcHQAdQ0oReqlLgrtcclTWSUrkriFZGpL7hori4i_Fs-m_2KP7g3Uw_x-UH9e3B8UfySijHw
CitedBy_id crossref_primary_10_3892_mmr_2025_13470
crossref_primary_10_1016_j_ijbiomac_2024_131091
crossref_primary_10_1080_14756366_2024_2367129
Cites_doi 10.1016/j.jacc.2008.05.049
10.1161/01.CIR.0000030184.70207.FF
10.1016/S0163‐7827(03)00014‐6
10.1016/S0735‐1097(98)00085‐0
10.1023/A:1015867031004
10.1345/aph.19415
10.1016/j.jacc.2006.10.074
10.1111/bph.14751
10.1073/pnas.0503723102
10.1016/0891‐5849(91)90192‐6
10.1038/bjp.2008.263
10.1016/S0828‐282X(10)70448‐7
10.1016/S0140‐6736(02)46032‐1
10.1073/pnas.122225199
10.1590/S0100‐879X1999001100001
10.1046/j.0306‐5251.2001.01495.x
10.1016/S0022-3565(25)11096-3
10.1016/j.jacc.2017.09.1064
10.1089/ars.2015.6376
10.1038/sj.bjp.0707116
10.1016/S0031-6997(25)06667-0
10.1042/bj20041354
10.1093/eurheartj/9.suppl_A.33
10.1172/JCI977
10.1172/jci118449
10.1016/S0022-3565(24)35295-4
10.1111/bcp.13804
10.1152/ajpheart.00693.2002
10.1046/j.1523‐1755.2003.00852.x
10.1067/mcp.2002.125293
10.1016/j.niox.2013.09.003
10.1161/01.atv.0000179599.71086.89
10.1161/01.RES.0000184694.03262.6d
10.1016/j.cbi.2017.03.012
10.1124/mol.107.035642
10.1056/nejm199802193380807
10.1074/jbc.M801182200
10.1016/j.atherosclerosis.2007.06.011
10.1161/hc3501.095358
10.1161/hc4601.099485
10.1039/C4RA13315C
10.1172/JCI26564
10.1161/01.CIR.0000138105.17864.6B
10.1111/acer.12215
10.3389/fphys.2013.00105
10.1111/bph.14752
10.1136/bmjopen‐2011‐000133
10.1016/0002‐9149(92)90588‐P
10.1111/j.1365‐2125.2007.02864.x
10.1007/s10557‐016‐6668‐z
10.1111/j.1469‐1809.2009.00517.x
10.1097/00005344‐199905000‐00002
10.1152/jappl.2001.91.3.1421
10.1093/cvr/cvn107
10.1021/tx4004787
ContentType Journal Article
Copyright 2023 British Pharmacological Society.
Copyright_xml – notice: 2023 British Pharmacological Society.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1111/bcp.15755
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1365-2125
EndPage 2774
ExternalDocumentID 37101414
10_1111_bcp_15755
BCP15755
Genre article
Journal Article
GrantInformation_xml – fundername: Canadian Institute for Health Research
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HYE
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
TEORI
TR2
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
NPM
7X8
ID FETCH-LOGICAL-c3255-d5d6a522571cb350c70ea8a45752b45a10cb6c6a0f2c219842337b8edcbedb4e3
IEDL.DBID DR2
ISSN 0306-5251
1365-2125
IngestDate Fri Jul 11 11:58:54 EDT 2025
Thu Apr 03 07:06:16 EDT 2025
Thu Aug 14 00:01:06 EDT 2025
Thu Apr 24 23:05:29 EDT 2025
Wed Jan 22 16:17:23 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords aldehyde dehydrogenase 2
nitroglycerin bioactivation
cardiovascular pharmacology
vitamin C
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2023 British Pharmacological Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3255-d5d6a522571cb350c70ea8a45752b45a10cb6c6a0f2c219842337b8edcbedb4e3
Notes The authors confirm that the Principal Investigator for this paper is Dr John D. Parker and that he had direct clinical responsibility for subjects.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-1949-2669
PMID 37101414
PQID 2806997624
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2806997624
pubmed_primary_37101414
crossref_citationtrail_10_1111_bcp_15755
crossref_primary_10_1111_bcp_15755
wiley_primary_10_1111_bcp_15755_BCP15755
PublicationCentury 2000
PublicationDate September 2023
2023-09-00
2023-Sep
20230901
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: September 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle British journal of clinical pharmacology
PublicationTitleAlternate Br J Clin Pharmacol
PublicationYear 2023
References 2001; 91
2013; 4
1991; 11
2002; 99
2000; 292
2014; 27
2016; 30
2008; 79
2007; 72
2017; 276
2001; 104
2005; 25
1992; 9
2010; 26
2017; 70
2005; 385
1991; 43
2005; 102
2002; 106
2007; 64
2008; 155
2008; 197
2003; 42
2001; 52
2003; 284
2015; 5
1992; 261
2011; 1
1998; 338
2008; 52
2006; 116
2008; 283
1996; 97
1879; 113
2015; 23
2004; 110
1992; 70
2009; 73
2007; 150
1988; 9
2019; 85
2013; 35
2000; 34
2014; 38
2005; 97
1999; 33
1999; 32
2002; 71
1998; 102
2003; 63
1998; 31
2007; 49
2019; 176
e_1_2_10_23_1
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_55_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_25_1
e_1_2_10_48_1
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_41_1
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_56_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_31_1
e_1_2_10_50_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_26_1
e_1_2_10_47_1
References_xml – volume: 30
  start-page: 367
  issue: 4
  year: 2016
  end-page: 378
  article-title: Vasodilator therapy: nitrates and Nicorandil
  publication-title: Cardiovasc Drugs Ther
– volume: 102
  start-page: 12159
  issue: 34
  year: 2005
  end-page: 12164
  article-title: An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation
  publication-title: Proc Natl Acad Sci U S A
– volume: 104
  start-page: 1119
  issue: 10
  year: 2001
  end-page: 1123
  article-title: Folic acid prevents nitroglycerin‐induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study
  publication-title: Circulation
– volume: 1
  issue: 1
  year: 2011
  article-title: Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial
  publication-title: BMJ Open
– volume: 176
  start-page: S247
  issue: Suppl 1
  year: 2019
  end-page: S296
  article-title: The concise guide to pharmacology 2019/20: catalytic receptors
  publication-title: Br J Pharmacol
– volume: 27
  start-page: 663
  issue: 4
  year: 2014
  end-page: 673
  article-title: Role of the lipid peroxidation product, 4‐hydroxynonenal, in the development of nitrate tolerance
  publication-title: Chem Res Toxicol
– volume: 72
  start-page: 191
  issue: 1
  year: 2007
  end-page: 196
  article-title: Bioactivation of nitroglycerin by ascorbate
  publication-title: Mol Pharmacol
– volume: 150
  start-page: 526
  issue: 4
  year: 2007
  end-page: 533
  article-title: Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH‐2−/− mice
  publication-title: Br J Pharmacol
– volume: 104
  start-page: 2673
  issue: 22
  year: 2001
  end-page: 2678
  article-title: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease
  publication-title: Circulation
– volume: 52
  start-page: 953
  issue: 11
  year: 2008
  end-page: 960
  article-title: Evidence for involvement of calcitonin gene‐related peptide in nitroglycerin response and association with mitochondrial aldehyde dehydrogenase‐2 (ALDH2) Glu504Lys polymorphism
  publication-title: J Am Coll Cardiol
– volume: 91
  start-page: 1421
  issue: 3
  year: 2001
  end-page: 1430
  article-title: Invited review: cGMP‐dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression
  publication-title: J Appl Physiol
– volume: 26
  start-page: 461
  issue: 9
  year: 2010
  end-page: 465
  article-title: Daily low‐dose folic acid supplementation does not prevent nitroglycerin‐induced nitric oxide synthase dysfunction and tolerance: a human in vivo study
  publication-title: Can J Cardiol
– volume: 33
  start-page: 685
  issue: 5
  year: 1999
  end-page: 690
  article-title: Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance
  publication-title: J Cardiovasc Pharmacol
– volume: 42
  start-page: 318
  issue: 4
  year: 2003
  end-page: 343
  article-title: 4‐Hydroxy‐2‐nonenal: a product and mediator of oxidative stress
  publication-title: Prog Lipid Res
– volume: 79
  start-page: 304
  issue: 2
  year: 2008
  end-page: 312
  article-title: Vascular tolerance to nitroglycerin in ascorbate deficiency
  publication-title: Cardiovasc Res
– volume: 338
  start-page: 520
  issue: 8
  year: 1998
  end-page: 531
  article-title: Nitrate therapy for stable angina pectoris
  publication-title: N Engl J Med
– volume: 283
  start-page: 17873
  issue: 26
  year: 2008
  end-page: 17880
  article-title: Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases
  publication-title: J Biol Chem
– volume: 197
  start-page: 383
  issue: 1
  year: 2008
  end-page: 391
  article-title: Intra‐arterial vitamin C prevents endothelial dysfunction caused by ischemia‐reperfusion
  publication-title: Atherosclerosis
– volume: 97
  start-page: 618
  issue: 7
  year: 2005
  end-page: 628
  article-title: Explaining the phenomenon of nitrate tolerance
  publication-title: Circ Res
– volume: 49
  start-page: 1289
  issue: 12
  year: 2007
  end-page: 1295
  article-title: Once daily therapy with isosorbide‐5‐mononitrate causes endothelial dysfunction in humans: evidence of a free‐radical‐mediated mechanism
  publication-title: J Am Coll Cardiol
– volume: 43
  start-page: 351
  issue: 3
  year: 1991
  end-page: 423
  article-title: Organic nitrate esters: clinical use and mechanisms of actions
  publication-title: Pharmacol Rev
– volume: 23
  start-page: 899
  issue: 11
  year: 2015
  end-page: 942
  article-title: Organic nitrate therapy, nitrate tolerance, and nitrate‐induced endothelial dysfunction: emphasis on redox biology and oxidative stress
  publication-title: Antioxid Redox Signal
– volume: 102
  start-page: 67
  issue: 1
  year: 1998
  end-page: 71
  article-title: Dietary supplement with vitamin C prevents nitrate tolerance
  publication-title: J Clin Invest
– volume: 31
  start-page: 1323
  issue: 6
  year: 1998
  end-page: 1329
  article-title: Randomized, double‐blind, placebo‐controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance
  publication-title: J Am Coll Cardiol
– volume: 9
  start-page: 1460
  issue: 11
  year: 1992
  end-page: 1464
  article-title: Glutathione S‐transferase‐mediated metabolism of glyceryl trinitrate in subcellular fractions of bovine coronary arteries
  publication-title: Pharm Res
– volume: 155
  start-page: 170
  issue: 2
  year: 2008
  end-page: 184
  article-title: The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles
  publication-title: Br J Pharmacol
– volume: 110
  start-page: 750
  issue: 6
  year: 2004
  end-page: 755
  article-title: Role of mitochondrial aldehyde dehydrogenase in nitroglycerin‐induced vasodilation of coronary and systemic vessels: an intact canine model
  publication-title: Circulation
– volume: 276
  start-page: 40
  year: 2017
  end-page: 45
  article-title: Vasodilatory effect of nitroglycerin in Japanese subjects with different aldehyde dehydrogenase 2 (ALDH2) genotypes
  publication-title: Chem Biol Interact
– volume: 116
  start-page: 506
  issue: 2
  year: 2006
  end-page: 511
  article-title: Mitochondrial aldehyde dehydrogenase‐2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin
  publication-title: J Clin Invest
– volume: 106
  start-page: 1460
  issue: 12
  year: 2002
  end-page: 1464
  article-title: High doses of vitamin C reverse endotoxin‐induced hyporeactivity to acetylcholine in the human forearm
  publication-title: Circulation
– volume: 71
  start-page: 440
  issue: 6
  year: 2002
  end-page: 447
  article-title: Angiotensin II attenuates the vasodilating effect of a nitric oxide donor, glyceryl trinitrate: roles of superoxide and angiotensin II type 1 receptors
  publication-title: Clin Pharmacol Ther
– volume: 25
  start-page: 1891
  issue: 9
  year: 2005
  end-page: 1895
  article-title: Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 97
  start-page: 562
  issue: 2
  year: 1996
  end-page: 576
  article-title: Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs
  publication-title: J Clin Invest
– volume: 99
  start-page: 8306
  issue: 12
  year: 2002
  end-page: 8311
  article-title: Identification of the enzymatic mechanism of nitroglycerin bioactivation
  publication-title: Proc Natl Acad Sci U S A
– volume: 38
  start-page: 44
  issue: 1
  year: 2014
  end-page: 50
  article-title: Dominance of the inactive Asian variant over activity and protein contents of mitochondrial aldehyde dehydrogenase 2 in human liver
  publication-title: Alcohol Clin Exp Res
– volume: 85
  start-page: 377
  issue: 2
  year: 2019
  end-page: 384
  article-title: The role of vascular endothelium in nitroglycerin‐mediated vasodilation
  publication-title: Br J Clin Pharmacol
– volume: 73
  start-page: 335
  issue: 3
  year: 2009
  end-page: 345
  article-title: Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant
  publication-title: Ann Hum Genet
– volume: 113
  start-page: 80
  issue: 2890
  year: 1879
  end-page: 81
  article-title: Nitro‐GLYCERINE as a remedy for angina pectoris
  publication-title: Lancet
– volume: 52
  start-page: 631
  issue: 6
  year: 2001
  end-page: 646
  article-title: Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications
  publication-title: Br J Clin Pharmacol
– volume: 32
  start-page: 1317
  issue: 11
  year: 1999
  end-page: 1327
  article-title: Cellular signaling with nitric oxide and cyclic GMP
  publication-title: Braz J Med Biol Res = Rev Bras Pesquis Med Biol
– volume: 292
  start-page: 326
  issue: 1
  year: 2000
  end-page: 330
  article-title: Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase
  publication-title: J Pharmacol Exp Ther
– volume: 64
  start-page: 145
  issue: 2
  year: 2007
  end-page: 150
  article-title: Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight
  publication-title: Br J Clin Pharmacol
– volume: 34
  start-page: 1193
  issue: 10
  year: 2000
  end-page: 1197
  article-title: Vitamin C in the prevention of nitrate tolerance
  publication-title: Ann Pharmacother
– volume: 284
  start-page: H698
  issue: 2
  year: 2003
  end-page: H703
  article-title: Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 176
  start-page: S297
  issue: Suppl 1
  year: 2019
  end-page: S396
  article-title: The concise guide to pharmacology 2019/20: enzymes
  publication-title: Br J Pharmacol
– volume: 70
  start-page: B4
  issue: 8
  year: 1992
  end-page: B10
  article-title: Biochemical mechanism of organic nitrate action
  publication-title: Am J Cardiol
– volume: 11
  start-page: 81
  issue: 1
  year: 1991
  end-page: 128
  article-title: Chemistry and biochemistry of 4‐hydroxynonenal, malonaldehyde and related aldehydes
  publication-title: Free Radic Biol Med
– volume: 35
  start-page: 116
  year: 2013
  end-page: 122
  article-title: Catalysis of nitrite generation from nitroglycerin by glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH)
  publication-title: Nitric Oxide
– volume: 261
  start-page: 716
  issue: 2
  year: 1992
  end-page: 723
  article-title: Hepatic cytochrome P‐450‐mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate
  publication-title: J Pharmacol Exp Ther
– volume: 5
  start-page: 27986
  issue: 35
  year: 2015
  end-page: 28006
  article-title: Free radicals, natural antioxidants, and their reaction mechanisms
  publication-title: RSC Adv
– volume: 63
  start-page: 1433
  issue: 4
  year: 2003
  end-page: 1442
  article-title: Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure
  publication-title: Kidney Int
– volume: 9
  start-page: 33
  issue: suppl A
  year: 1988
  end-page: 37
  article-title: Pharmacokinetics of organic nitrates in man: an overview
  publication-title: Eur Heart J
– volume: 385
  start-page: 769
  issue: 3
  year: 2005
  end-page: 777
  article-title: Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide
  publication-title: Biochem J
– volume: 70
  start-page: 2393
  issue: 19
  year: 2017
  end-page: 2410
  article-title: The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics
  publication-title: J am Coll Cardiol
– volume: 4
  year: 2013
  article-title: Angiotensin‐II‐derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives
  publication-title: Front Physiol
– ident: e_1_2_10_25_1
  doi: 10.1016/j.jacc.2008.05.049
– ident: e_1_2_10_37_1
  doi: 10.1161/01.CIR.0000030184.70207.FF
– ident: e_1_2_10_29_1
  doi: 10.1016/S0163‐7827(03)00014‐6
– ident: e_1_2_10_55_1
  doi: 10.1016/S0735‐1097(98)00085‐0
– ident: e_1_2_10_12_1
  doi: 10.1023/A:1015867031004
– ident: e_1_2_10_32_1
  doi: 10.1345/aph.19415
– ident: e_1_2_10_34_1
  doi: 10.1016/j.jacc.2006.10.074
– ident: e_1_2_10_42_1
  doi: 10.1111/bph.14751
– ident: e_1_2_10_45_1
  doi: 10.1073/pnas.0503723102
– ident: e_1_2_10_28_1
  doi: 10.1016/0891‐5849(91)90192‐6
– ident: e_1_2_10_43_1
  doi: 10.1038/bjp.2008.263
– ident: e_1_2_10_39_1
  doi: 10.1016/S0828‐282X(10)70448‐7
– ident: e_1_2_10_3_1
  doi: 10.1016/S0140‐6736(02)46032‐1
– ident: e_1_2_10_15_1
  doi: 10.1073/pnas.122225199
– ident: e_1_2_10_9_1
  doi: 10.1590/S0100‐879X1999001100001
– ident: e_1_2_10_33_1
  doi: 10.1046/j.0306‐5251.2001.01495.x
– ident: e_1_2_10_11_1
  doi: 10.1016/S0022-3565(25)11096-3
– ident: e_1_2_10_4_1
  doi: 10.1016/j.jacc.2017.09.1064
– ident: e_1_2_10_44_1
  doi: 10.1089/ars.2015.6376
– ident: e_1_2_10_20_1
  doi: 10.1038/sj.bjp.0707116
– ident: e_1_2_10_8_1
  doi: 10.1016/S0031-6997(25)06667-0
– ident: e_1_2_10_19_1
  doi: 10.1042/bj20041354
– ident: e_1_2_10_5_1
  doi: 10.1093/eurheartj/9.suppl_A.33
– ident: e_1_2_10_31_1
  doi: 10.1172/JCI977
– ident: e_1_2_10_51_1
  doi: 10.1172/jci118449
– ident: e_1_2_10_14_1
  doi: 10.1016/S0022-3565(24)35295-4
– ident: e_1_2_10_38_1
  doi: 10.1111/bcp.13804
– ident: e_1_2_10_50_1
  doi: 10.1152/ajpheart.00693.2002
– ident: e_1_2_10_47_1
  doi: 10.1046/j.1523‐1755.2003.00852.x
– ident: e_1_2_10_53_1
  doi: 10.1067/mcp.2002.125293
– ident: e_1_2_10_13_1
  doi: 10.1016/j.niox.2013.09.003
– ident: e_1_2_10_24_1
  doi: 10.1161/01.atv.0000179599.71086.89
– ident: e_1_2_10_54_1
  doi: 10.1161/01.RES.0000184694.03262.6d
– ident: e_1_2_10_22_1
  doi: 10.1016/j.cbi.2017.03.012
– ident: e_1_2_10_17_1
  doi: 10.1124/mol.107.035642
– ident: e_1_2_10_2_1
  doi: 10.1056/nejm199802193380807
– ident: e_1_2_10_16_1
  doi: 10.1074/jbc.M801182200
– ident: e_1_2_10_35_1
  doi: 10.1016/j.atherosclerosis.2007.06.011
– ident: e_1_2_10_40_1
  doi: 10.1161/hc3501.095358
– ident: e_1_2_10_36_1
  doi: 10.1161/hc4601.099485
– ident: e_1_2_10_48_1
  doi: 10.1039/C4RA13315C
– ident: e_1_2_10_26_1
  doi: 10.1172/JCI26564
– ident: e_1_2_10_18_1
  doi: 10.1161/01.CIR.0000138105.17864.6B
– ident: e_1_2_10_46_1
  doi: 10.1111/acer.12215
– ident: e_1_2_10_52_1
  doi: 10.3389/fphys.2013.00105
– ident: e_1_2_10_41_1
  doi: 10.1111/bph.14752
– ident: e_1_2_10_23_1
  doi: 10.1136/bmjopen‐2011‐000133
– ident: e_1_2_10_7_1
  doi: 10.1016/0002‐9149(92)90588‐P
– ident: e_1_2_10_49_1
  doi: 10.1111/j.1365‐2125.2007.02864.x
– ident: e_1_2_10_6_1
  doi: 10.1007/s10557‐016‐6668‐z
– ident: e_1_2_10_21_1
  doi: 10.1111/j.1469‐1809.2009.00517.x
– ident: e_1_2_10_56_1
  doi: 10.1097/00005344‐199905000‐00002
– ident: e_1_2_10_10_1
  doi: 10.1152/jappl.2001.91.3.1421
– ident: e_1_2_10_30_1
  doi: 10.1093/cvr/cvn107
– ident: e_1_2_10_27_1
  doi: 10.1021/tx4004787
SSID ssj0013165
Score 2.4297333
Snippet Aims To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The...
To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2767
SubjectTerms aldehyde dehydrogenase 2
cardiovascular pharmacology
nitroglycerin bioactivation
vitamin C
Title The effect of vitamin C on nitroglycerin‐mediated vasodilation in individuals with and without the aldehyde dehydrogenase 2 polymorphism
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbcp.15755
https://www.ncbi.nlm.nih.gov/pubmed/37101414
https://www.proquest.com/docview/2806997624
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9wwFBYhp166pNu0TXktJeQQD17kZcipHRpCoWUoCeRQMFretKYz1hB7As4p557yG_tL-iSNZ5ouUAoGGyQLS37L96S3MPYqzzHVoRIBRnkWcDnFYKQ5Bih5zHMUpPPt1sD7D9nxKX93lp5tscM-Fsbnh1hvuFnOcPLaMriQzU9MLtViGBHYsAHm1lfLAqKP8eYEIXJlJC0kJmMrjVZZhawXz_rNm7roN4B5E686hXN0h33qP9X7mXwdLls5VJe_ZHH8z7ncZbdXQBRee8q5x7aw3mF7E5_JujuAk01gVnMAezDZ5Lju7rNv1AzeFwTMFC6qVsyrGsZgaiAhcW4-zzplIwu_X1274BQCtnAhGqMr73wHlb36YLAG7H4wiFq7B7NsgYApiJnGL51GcDcaFGtSuhDDwsy6uSESqZr5A3Z69PZkfBysyjoEKiEDJtCpzgTBvjSPlEzSUOUhikJwmn8seSqiUMlMZSKcxorkaUGAL8llgVpJ1JJj8pBt16bGxwxSQnfFlOvRCJHsKCELh9-4IhkfylAP2H7_g0u1ynluS2_Myt72oZUv3coP2Mt114VP9PGnTi96KimJDe3ZiqjRLJvSHlCPCNrFfMAeefJZD5PktiByRC37jgj-Pn75ZjxxD0_-vetTdism4OX93p6x7fZ8ibsElFr53HHED3dYEjc
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9RAEG7W9aAX34_xWYose9gMeXQnGfCig8uou8sgs7AXCf2o0eBMMmwyC_Hk2ZO_0V9idWcy4_oAEQIJdKdJd6qqv6quB2PPkgSF8bX0MEhij6spegPD0UPFQ56gpD3fmgYOj-LRMX9zIk622PMuFqbND7E2uFnOcPLaMrg1SP_E5Uov-gGhDXGBXbQVvZ1C9S7cnCEErpCkBcWkbolglVfI-vGsXz2_G_0GMc8jVrfl7F9l77uPbT1NPvWXterrz7_kcfzf2VxjV1ZYFF60xHOdbWFxg-2M22TWzR5MNrFZ1R7swHiT5rq5yb5SM7TuIFBO4Syv5TwvYAhlASQnTssPs0bb4MLvX765-BTCtnAmq9Lkrf8d5Pbq4sEqsCZhkIVxD-WyBsKmIGcGPzYGwd1oUCxo34UQFuWsmZdEJXk1v8WO919NhiNvVdnB0xHpMJ4RJpaE_EQSaBUJXyc-ylRymn-ouJCBr1WsY-lPQ00iNSXMFyUqRaMVGsUxus22i7LAuwwEAbx0ys1ggEiqlFSpg3Bck5j3lW96bLf7w5lepT231TdmWaf-0MpnbuV77Om666LN9fGnTk86MsmIE-3xiiywXFaZPaMeELoLeY_daelnPUyU2JrIAbXsOir4-_jZy-HYPdz7966P2aXR5PAgO3h99PY-uxwSDmvd4B6w7fp0iQ8JN9XqkWOPH3toFlI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9tAFB7SFEovabrGXV9LCTlERstoMT21Tk26BVMSyKEgZnlqRGzJRHJAPfWcU39jf0nfjCy76QKlIJBgRoNm9JbvzbyFsedxjKF2lXDQiyOHywydgebooOQ-j1GQzjdbAx8Oov0j_vY4PF5jL7pYmDY_xHLDzXCGldeGwWc6-4nJpZr1PQIb4RV2lUduYkh676O_OkLwbB1Jg4nJ2gq9RVoh48azfPWyMvoNYV4GrFbjjG6wT923to4mp_15Lfvqyy9pHP9zMptsY4FE4WVLOjfZGha32Pa4TWXd7MLhKjKr2oVtGK-SXDe32QU1Q-sMAmUG53ktpnkBQygLIClxVn6eNMqEFn7_-s1GpxCyhXNRlTpvve8gN1cXDVaB2RAGUWj7UM5rIGQKYqLxpNEI9kaDYkFaF3yYlZNmWhKN5NX0DjsavT4c7juLug6OCsiCcXSoI0G4L4w9JYPQVbGLIhGc5u9LHgrPVTJSkXAzX5FATQjxBbFMUCuJWnIM7rL1oixwi0FI8C7JuB4MEMmQEjKxAI4rEvKudHWP7XQ_OFWLpOem9sYk7YwfWvnUrnyPPVt2nbWZPv7U6WlHJSnxoTlcEQWW8yo1J9QDwnY-77F7LfkshwliUxHZo5YdSwR_Hz99NRzbh_v_3vUJuzbeG6Xv3xy8e8Cu-wTCWh-4h2y9PpvjIwJNtXxsmeMHURIVCg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+vitamin+C+on+nitroglycerin-mediated+vasodilation+in+individuals+with+and+without+the+aldehyde+dehydrogenase+2+polymorphism&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=He%2C+Jerry+D&rft.au=Parker%2C+John+D&rft.date=2023-09-01&rft.issn=1365-2125&rft.eissn=1365-2125&rft.volume=89&rft.issue=9&rft.spage=2767&rft_id=info:doi/10.1111%2Fbcp.15755&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon